Diabetic endothelial dysfunction: the role of poly (ADP-ribose) polymerase activation F Garcia Soriano, L Virag, P Jagtap, E Szabo, JG Mabley, L Liaudet, ... Nature medicine 7 (1), 108-113, 2001 | 788 | 2001 |
Adenosine inhibits IL‐12 and TNF‐α production via adenosine A2a receptor‐dependent and independent mechanisms G Haskó, DG Kuhel, JF Chen, MA Schwarzschild, EA Deitch, JG Mabley, ... The FASEB Journal 14 (13), 2065-2074, 2000 | 600 | 2000 |
Role of nitrosative stress and peroxynitrite in the pathogenesis of diabetic complications. Emerging new therapeutical strategies P Pacher, IG Obrosova, JG Mabley, C Szabó Current medicinal chemistry 12 (3), 267-275, 2005 | 465 | 2005 |
Inosine inhibits inflammatory cytokine production by a posttranscriptional mechanism and protects against endotoxin-induced shock G Haskó, DG Kuhel, ZH Németh, JG Mabley, RF Stachlewitz, L Virág, ... The Journal of Immunology 164 (2), 1013-1019, 2000 | 373 | 2000 |
The role of poly (ADP-ribose) polymerase activation in the development of myocardial and endothelial dysfunction in diabetes P Pacher, L Liaudet, FG Soriano, JG Mabley, E Szabo, C Szabo Diabetes 51 (2), 514-521, 2002 | 371 | 2002 |
Potent metalloporphyrin peroxynitrite decomposition catalyst protects against the development of doxorubicin-induced cardiac dysfunction P Pacher, L Liaudet, P Bai, JG Mabley, PM Kaminski, L Virág, A Deb, ... Circulation 107 (6), 896-904, 2003 | 356 | 2003 |
Rapid reversal of the diabetic endothelial dysfunction by pharmacological inhibition of poly (ADP-ribose) polymerase FG Soriano, P Pacher, J Mabley, L Liaudet, C Szabó Circulation research 89 (8), 684-691, 2001 | 262 | 2001 |
Protection against hemorrhagic shock in mice genetically deficient in poly (ADP-ribose) polymerase L Liaudet, FG Soriano, É Szabo, L Virág, JG Mabley, AL Salzman, ... Proceedings of the National academy of Sciences 97 (18), 10203-10208, 2000 | 259 | 2000 |
Novel phenanthridinone inhibitors of poly (adenosine 5′-diphosphate-ribose) synthetase: potent cytoprotective and antishock agents P Jagtap, FG Soriano, L Virág, L Liaudet, J Mabley, É Szabó, G Haskó, ... Critical care medicine 30 (5), 1071-1082, 2002 | 248 | 2002 |
Activation of poly (ADP-Ribose) polymerase-1 is a central mechanism of lipopolysaccharide-induced acute lung inflammation L Liaudet, PÁL Pacher, JG Mabley, L Virág, FG Soriano, G Haskó, ... American journal of respiratory and critical care medicine 165 (3), 372-377, 2002 | 247 | 2002 |
Activation of poly (ADP-ribose) polymerase contributes to development of doxorubicin-induced heart failure P Pacher, L Liaudet, P Bai, L Virag, JG Mabley, G Hasko, C Szabo Journal of Pharmacology and Experimental Therapeutics 300 (3), 862-867, 2002 | 236 | 2002 |
Part I: pathogenetic role of peroxynitrite in the development of diabetes and diabetic vascular complications: studies with FP15, a novel potent peroxynitrite decomposition … C Szabó, JG Mabley, SM Moeller, R Shimanovich, P Pacher, L Virág, ... Molecular Medicine 8, 571-580, 2002 | 228 | 2002 |
Role for nitrosative stress in diabetic neuropathy: evidence from studies with a peroxynitrite decomposition catalyst IG Obrosova, JG Mabley, Z Zsengellér, T Charniauskaya, OI Abatan, ... Kluwer Academic/Plenum Publishers, 2005 | 192 | 2005 |
Resistance to acute septic peritonitis in poly (ADP-ribose) polymerase-1-deficient mice FG Soriano, L Liaudet, E Szabo, L Virág, JG Mabley, P Pacher, C Szabo Shock 17 (4), 286-292, 2002 | 191 | 2002 |
Anti-inflammatory effects of a novel, potent inhibitor of poly (ADP-ribose) polymerase JG Mabley, P Jagtap, M Perretti, SJ Getting, AL Salzman, L Virag, ... Inflammation Research 50, 561-569, 2001 | 174 | 2001 |
Left ventricular pressure-volume relationship in a rat model of advanced aging-associated heart failure P Pacher, JG Mabley, L Liaudet, OV Evgenov, A Marton, G Haskó, ... American Journal of Physiology-Heart and Circulatory Physiology, 2004 | 164 | 2004 |
Flagellin from gram-negative bacteria is a potent mediator of acute pulmonary inflammation in sepsis L Liaudet, C Szabó, OV Evgenov, KG Murthy, P Pacher, L Virág, ... Shock 19 (2), 131-137, 2003 | 164 | 2003 |
The adenosine A3 receptor agonist, N6-(3-iodobenzyl)-adenosine-5′-N-methyluronamide, is protective in two murine models of colitis J Mabley, F Soriano, P Pacher, G Haskó, A Marton, R Wallace, A Salzman, ... European journal of pharmacology 466 (3), 323-329, 2003 | 139 | 2003 |
Potential role for 8‐oxoguanine DNA glycosylase in regulating inflammation JG Mabley, P Pacher, A Deb, R Wallace, RH Elder, C Szabó The FASEB journal 19 (2), 1-18, 2005 | 137 | 2005 |
Adenosine receptor activation ameliorates type 1 diabetes ZH Németh, D Bleich, B Csóka, P Pacher, JG Mabley, L Himer, ES Vizi, ... The FASEB journal: official publication of the Federation of American …, 2007 | 136 | 2007 |